-
RegMed XB is a translational product development platform that brings together Dutch and Flemish public and private stakeholders to accelerate the development of innovative regenerative therapies.
Infrastructure: RegMed XB's Pilot Factory
A seamless pathway for innovators to accelerate, de-risk, and scale regenerative therapies
read more
-
The Influence of OAT1 Density and Functionality on Indoxyl Sulfate Transport in the Human Proximal Tubule
Jasia King, Silvia M. Mihaila, Sabbir Ahmed, Roman Truckenmüller, Stefan Giselbrecht, Rosalinde Masereeuw and Aurélie Carlier from MERLN Institute for Technology-Inspires Medicine, Maastricht University and Division of Pharmacology.
read more
Ten steps to investigate a cellular system with Mathematical modeling
Jasia King and Kerbaï Saïd Eroumé of MERLN Institute of Maastricht University have published the article “Ten steps to investigate a cellular system with mathematical modeling” in the scientific journal PLOS computational modeling.
read more
Why Definitions Matter and Why We May Need One for Embryo-Like Structures
Think of a cube. What is its size? What is its color? What is the structure of its surface like?
read more
Is the cube solid or hollow? Is it tiny or massive? Transparent or opaque? -
Moonshots (research excellence)
-
Pilot Factory (infrastructure)
The RegMed XB Pilot Factory is one of the largest international infrastructures for regenerative medicine. It brings together all the expertise and infrastructure needed to bring regenerative medicine to the market.
-
RegMed XB's Ecosystem
Health Foundations
The following Dutch health foundations are involved in defining research objectives and provide guidance in the research we conduct to ensure we maintain focus on the patient.
read moreAcademic Partners
RegMed XB works together with (inter)national top-rated academic institutions and collaborates specifically and exclusively with researchers who contribute specific expertise to the Moonshot initiatives.
read moreIndustrial Partners
Partnering with companies offers access to their expertise in designing scalable and feasible products. Currently, we have strong partnerships with the following entities.
read moreGovernmental Partners
RegMed XB receives support from national and local governments to de-risk promising concepts from academia to proof of concept or initial clinical trial stages.
read more -
-
-
-
-
-
-
